The heart failure revascularisation trial (HEART): rationale, design and methodology.
about
Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac resynchronisation therapy in heart failurePrevalence of scarred and dysfunctional myocardium in patients with heart failure of ischaemic origin: a cardiovascular magnetic resonance studyPatients with treatable malignant diseases--including heart failure--are entitled to specialist care.Noninvasive assessment myocardial viability: current status and future directions.Stress echocardiography for the diagnosis and risk stratification of patients with suspected or known coronary artery disease: a critical appraisal. Supported by the British Society of Echocardiography.TLR4 Expression Is Associated with Left Ventricular Dysfunction in Patients Undergoing Coronary Artery Bypass SurgeryClinical decision-making and myocardial viability: current perspectives.Hibernating myocardium in heart failure.Long term prognosis of heart failure after acute coronary syndromes without ST elevation.Cardiac resynchronization therapy as an adjunct to conventional surgical treatment for heart failure.Clinical trials update from the American College of Cardiology 2009: ADMIRE-HF, PRIMA, STICH, REVERSE, IRIS, partial ventricular support, FIX-HF-5, vagal stimulation, REVIVAL-3, pre-RELAX-AHF, ACTIVE-A, HF-ACTION, JUPITER, AURORA, and OMEGA.Myocardial viability imaging and revascularization in chronic ischemic left ventricular systolic dysfunction.A pathway and network review on beta-adrenoceptor signaling and beta blockers in cardiac remodeling.SPECT and PET in ischemic heart failure.To revascularize or not to revascularize: a dilemma in heart failure.Myocardial metabolic manipulation: a new therapeutic approach in heart failure?Hibernating myocardium: high or low risk?Clinical trials update from the American College of Cardiology meeting 2010: DOSE, ASPIRE, CONNECT, STICH, STOP-AF, CABANA, RACE II, EVEREST II, ACCORD, and NAVIGATOR.Cardiac resynchronization therapy in pacemaker-dependent patients with left ventricular dysfunction.Clinical trials update from Heart Rhythm 2008 and Heart Failure 2008: ATHENA, URGENT, INH study, HEART and CK-1827452.The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure.Natriuretic peptides for heart failure. Fashionable? Useful? Necessary?Clinical trials update from the American College of Cardiology 2007: ALPHA, EVEREST, FUSION II, VALIDD, PARR-2, REMODEL, SPICE, COURAGE, COACH, REMADHE, pro-BNP for the evaluation of dyspnoea and THIS-diet.Clinical trials update from the American Heart Association 2006: OAT, SALT 1 and 2, MAGIC, ABCD, PABA-CHF, IMPROVE-CHF, and percutaneous mitral annuloplasty.
P2860
Q28168872-B15A77BE-EDC4-4418-9242-9614387283C1Q30473748-B04D68E3-A6E9-42A1-9E88-376CF26FA887Q33713403-C1C001D7-AE00-4411-8CF7-37E69137D15AQ34774619-CB7CBE85-EC12-4306-891C-6DEEFAC2F2D9Q35583887-772D4BAE-7592-4EC0-B7E5-CE97F81D820FQ35648432-1C75C304-84B5-4422-B7D1-3B47A5D4E210Q36037551-FAB6070E-70E8-4195-A44C-777C6D93ABFDQ36050499-C19AE667-B6E7-4DC7-A3D6-5B2C7BA7B1E4Q36928252-038EBCC4-7F3C-4B84-89DD-24CF102B904AQ36932125-0C61D862-9337-456A-984E-27D4B2671F63Q37495281-5318A635-E22B-4AC7-806D-6B4AC867A162Q37656286-490A2B97-B6B6-4D08-B639-1B3C8D0C365CQ38173671-090C6BB8-2797-4AC6-9587-0A87EC4FE916Q38985171-F7C22677-E6BD-47A8-8078-B5EA70D6E8FEQ41886589-DD537D61-E8FD-4778-94B6-2D52E1F0B2FAQ43012953-D37EB8EB-7344-4F22-8519-828E0F2369D5Q43013810-C868C64D-1E28-4FE7-842B-A5A4421A1BABQ43055364-4CBD76BA-A2D0-40AA-B3EF-21DA42D64FEFQ45282222-2640F021-C83E-4A0B-9896-637A9F823B1DQ46446962-81519A6C-D81C-461B-918D-5847D60B8A0AQ46635614-CA3D65D6-E581-4E24-978A-D5A826575748Q48030240-A2377711-F474-48C8-AABF-48501268A91FQ48178091-3B37E182-F3E9-4754-98BF-F969A11EAD29Q53581144-2965B5EF-2D01-458A-89C0-AFF7F3FF6AD2
P2860
The heart failure revascularisation trial (HEART): rationale, design and methodology.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
The heart failure revascularisation trial (HEART): rationale, design and methodology.
@ast
The heart failure revascularisation trial (HEART): rationale, design and methodology.
@en
type
label
The heart failure revascularisation trial (HEART): rationale, design and methodology.
@ast
The heart failure revascularisation trial (HEART): rationale, design and methodology.
@en
prefLabel
The heart failure revascularisation trial (HEART): rationale, design and methodology.
@ast
The heart failure revascularisation trial (HEART): rationale, design and methodology.
@en
P2093
P2860
P50
P1476
The heart failure revascularisation trial (HEART): rationale, design and methodology
@en
P2093
D J Pennell
J Eastaugh
M S Norell
R S Bonser
P2860
P304
P356
10.1016/S1388-9842(03)00056-4
P577
2003-06-01T00:00:00Z